Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Reported Russian COVID vaccine disinformation 'reprehensible' - UK's Raab

Fri, 16th Oct 2020 07:59

LONDON, Oct 16 (Reuters) - British Foreign Secretary Dominic
Raab said on Friday a reported Russian disinformation campaign
to undermine COVID-19 vaccine trials was "reprehensible" at a
time when countries should be coming together.

"We know that Russia has a track record in this area," he
told Sky News when asked about a Times newspaper report that
there was a Russian campaign to undermine an Oxford University
vaccine trial.

"Anyone trying to basically sabotage the efforts of those
trying to develop a vaccine are deeply reprehensible, and it's
pretty unacceptable and unjustified in any circumstances."
(Reporting by Guy Faulconbridge and Paul Sandle; editing by
Michael Holden)

Related Shares

More News

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

7 May 21 09:49

All under-40s to be offered alternative to AstraZeneca vaccine

All under-40s to be offered alternative to AstraZeneca vaccine

7 May 21 08:49

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

AstraZeneca reports positive results in Phase 3 lung cancer drug trial

7 May 21 08:32

AstraZeneca's Imfinzi demonstrates benefit in combination with antibody

(Sharecast News) - AstraZeneca reported on Friday that 'Imfinzi' and tremelimumab with chemotherapy demonstrated an overall survival benefit in the 'POSEIDON' trial for first-line stage four non-small cell lung cancer, making it the first phase 3 trial to demonstrate an overall survival benefit with tremelimumab.

7 May 21 07:42

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.